ENTPD1-AS1–miR-144-3p-mediated high expression of COL5A2 correlates with poor prognosis and macrophage infiltration in gastric cancer

Figure 1 COL5A2 was upregulated in pan cancer and associated with the overall survival of gastric cancer. A: Analysis of COL5A2 expression in 9 types of cancer by Gene Expression Profiling Interactive Analysis database; B: Associations of COL5A2 expression with the overall survival (OS) in Breast invasive carcinoma; C: Associations of COL5A2 expression with the OS in Cholangio carcinoma; D: Associations of COL5A2 expression with the OS in esophageal carcinoma; E: Associations of COL5A2 expression with the OS in Glioblastoma multiforme; F: Associations of COL5A2 expression with the OS in head and neck squamous cell carcinoma; G: Associations of COL5A2 expression with the OS in kidney renal clear cell carcinoma; H: Associations of COL5A2 expression with the OS in prostate adenocarcinoma; I: Associations of COL5A2 expression with the OS in Uterine Corpus Endometrial Carcinoma; J: Associations of COL5A2 expression with the OS in stomach adenocarcinoma. ^aP < 0.05. BRCA: Breast invasive carcinoma; CHOL: Cholangio carcinoma; ESCA: Esophageal carcinoma; GBM: Glioblastoma multiforme; HNSC: Head and Neck squamous cell carcinoma; KIRC: kidney renal clear cell carcinoma; PRAD: Prostate adenocarcinoma; UCEC: Uterine Corpus Endometrial Carcinoma; STAD: Stomach adenocarcinoma.